000			03315nam a22003975i 4500
001			309927
003			MX-SnUAN
005			20160429160331.0
007			cr nn 008mamaa
008			150903s2007 sz | o |||| 0|eng d
020			_a9783764375638 _99783764375638
024	7		_a10.1007/9783764375638 _2doi
035			_avtls000362796
039		9	_a201509031020 _bVLOAD _c201405070334 _dVLOAD _y201402211058 _zstaff
040			_aMX-SnUAN _bspa _cMX-SnUAN _erda
050		4	_aQR46
100	1		_aSuttorp, Norbert. _eautor _9350431
245	1	0	_aCommunity-Acquired Pneumonia / _cby Norbert Suttorp, Tobias Welte, Reinhard Marre.
264		1	_aBasel : _bBirkhäuser Basel, _c2007.
300			_aviii, 250 páginas _brecurso en línea.
336			_atexto _btxt _2rdacontent
337			_acomputadora _bc _2rdamedia
338			_arecurso en línea _bcr _2rdacarrier
347			_aarchivo de texto _bPDF _2rda
490	0		_aBirkhäuser Advances in Infectious Diseases
500			_aSpringer eBooks
505	0		_aDiagnosis and treatment of community acquired pneumonia - the German perspective -- Detection of respiratory bacterial pathogens -- Viral pathogens and epidemiology, detection, therapy and resistance -- Resistance in Streptococcus pneumoniae -- Influenza -- Pathogenesis of Chlamydophila pneumoniae infections — epidemiology, immunity, cell biology, virulence factors -- Legionnaires’ disease and its agent Legionella pneumophila -- Pathogenesis of Streptococcus pneumoniae infections:adaptive immunity, innate immunity, cell biology, virulence factors -- Pathogenesis of Mycoplasma pneumoniae infections:adaptive immunity, innate immunity, cell biology, and virulence factors -- Community-acquired pneumonia: paving the way towards new vaccination concepts.
520			_aCommunity-acquired pneumonia (CAP) is a disease associated with high morbidity and mortality, with at least one third of cases requiring hospitalization, exceeding the numbers admitted for myocardial infarction and stroke. Despite a broad armamentarium of antimicrobials available, it remains an important cause of death in industrialized countries. CAP is caused by a variety of pathogens with their order of importance dependent on the location and population studied. Despite the importance of CAP, reliable data and a recommended evidence-based therapy are lacking, and basic research must be improved. The goal of this volume is to present state-of-the-art knowledge on epidemiology, clinical presentation, immunology, pathology, and diagnosis including the identification of "new pathogens". Therapeutic approaches, antibiotics resistance, disease management and vaccination strategies are also covered. The volume is of interest to researchers and clinicians in virology, epidemiology and biomedicine.
590			_aPara consulta fuera de la UANL se requiere clave de acceso remoto.
700	1		_aWelte, Tobias. _eautor _9350432
700	1		_aMarre, Reinhard. _eautor _9350433
710	2		_aSpringerLink (Servicio en línea) _9299170
776	0	8	_iEdición impresa: _z9783764375621
856	4	0	_uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-7643-7563-8 _zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942			_c14
999			_c309927 _d309927